Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e089927 - PMID: 39785619 - DOI: 10.1002/alz.089927
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e086293 - PMID: 39785544 - DOI: 10.1002/alz.086293
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e091415 - PMID: 39785462 - DOI: 10.1002/alz.091415
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e093205 - PMID: 39785302 - DOI: 10.1002/alz.093205
Public Health.
Alzheimers Dement. 2024;20 Suppl 7:e091037 - PMID: 39784872 - DOI: 10.1002/alz.091037
Public Health.
Alzheimers Dement. 2024;20 Suppl 7:e089624 - PMID: 39784818 - DOI: 10.1002/alz.089624
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e090893 - PMID: 39784207 - DOI: 10.1002/alz.090893
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e091824 - PMID: 39784074 - DOI: 10.1002/alz.091824
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e095237 - PMID: 39783725 - DOI: 10.1002/alz.095237
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e094824 - PMID: 39783465 - DOI: 10.1002/alz.094824
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e095630 - PMID: 39783408 - DOI: 10.1002/alz.095630
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e095547 - PMID: 39783363 - DOI: 10.1002/alz.095547
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e095635 - PMID: 39783135 - DOI: 10.1002/alz.095635
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093782 - PMID: 39783119 - DOI: 10.1002/alz.093782
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093683 - PMID: 39783095 - DOI: 10.1002/alz.093683
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093913 - PMID: 39783010 - DOI: 10.1002/alz.093913
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093920 - PMID: 39782985 - DOI: 10.1002/alz.093920
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093936 - PMID: 39782961 - DOI: 10.1002/alz.093936
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e094128 - PMID: 39782872 - DOI: 10.1002/alz.094128
Drug Development.
Alzheimers Dement. 2024;20 Suppl 6(Suppl 6):e085111 - PMID: 39782523 - PMCID: PMC11712541 - DOI: 10.1002/alz.085111
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.
J Nucl Med. 2025;66(Suppl 2):S5-S31 - PMID: 39778970 - PMCID: PMC12794165 - DOI: 10.2967/jnumed.124.268756
Regional Variations in the Management of Cerebral Arteriovenous Malformations: A Nationwide Inpatient Sample Analysis of Surgical Excision and Endovascular Embolization.
J Clin Neurosci. 2025;133:110987 - PMID: 39778411 - DOI: 10.1016/j.jocn.2024.110987
A specific and adaptable approach to track CD206+ macrophages by molecular MRI and fluorescence imaging.
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.
Indocyanine Blue (ICB) as a Functional Alternative to Indocyanine Green (ICG) for Enhanced 700 nm NIR Imaging.
Selective use of ferumoxytol-enhanced magnetic resonance angiography in patients with renal insufficiency: insights from a pilot study.
Int J Cardiovasc Imaging. 2025;42(1):29-35 - PMID: 39870959 - DOI: 10.1007/s10554-025-03337-6
Impaired Visuospatial Processing in Cerebral Visual Impairment Revealed by Performance on a Conjunction Visual Search Task.
Br J Vis Impair. 2023;42(3):587-598 - PMID: 39850325 - PMCID: PMC11756917 - DOI: 10.1177/02646196231187550
Depressive Symptoms and Amyloid Pathology.
JAMA Psychiatry. 2025;82(3):296-310 - PMID: 39841452 - PMCID: PMC11883504 - DOI: 10.1001/jamapsychiatry.2024.4305
Spleen stiffness in a healthy pediatric population undergoing liver magnetic resonance elastography.
Pediatr Radiol. 2025;55(4):846-856 - PMID: 39841253 - PMCID: PMC11982077 - DOI: 10.1007/s00247-024-06107-z
Commentary: Comparing magnetic resonance enterography and endoscopy findings to the motility of magnetic resonance imaging in pediatric Crohn's disease.
Pediatr Radiol. 2025;55(5):1021-1023 - PMID: 39891732 - DOI: 10.1007/s00247-025-06171-z
Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts.
Geroscience. 2025;47(4):5619-5634 - PMID: 39888585 - PMCID: PMC12397043 - DOI: 10.1007/s11357-025-01528-6
Response by Grune and Nahrendorf to Letter Regarding Article, "Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart".
Circulation. 2025;151(5):e35-e36 - PMID: 39899631 - DOI: 10.1161/CIRCULATIONAHA.124.072688
International standardization of pediatric magnetic resonance imaging protocols: creation of the World Federation of Pediatric Imaging MR Protocols Committee.
Pediatr Radiol. 2025;55(3):375-383 - PMID: 39903262 - DOI: 10.1007/s00247-024-06154-6
Global Sensitivity Analysis of a Novel Signaling Network for Heart Growth With Local IGF1 Production.
Int J Numer Method Biomed Eng. 2025;41(2):e3906 - PMID: 39924146 - PMCID: PMC11807724 - DOI: 10.1002/cnm.3906
Thalamic Volume Reduction in Cerebral Visual Impairment: Relationship to Visual Dysfunction.
J Child Neurol. 2025;40(6):403-414 - PMID: 39962823 - PMCID: PMC12092204 - DOI: 10.1177/08830738251316406
[18F]MK-6240 Radioligand Delivery Indices as Surrogates of Cerebral Perfusion: Bias and Correlation Against [15O]Water.
J Nucl Med. 2025;66(3):410-417 - PMID: 39947916 - PMCID: PMC11876731 - DOI: 10.2967/jnumed.124.268701
Next generation drug clearance insights: real-time tracking in hepatobiliary and renal systems.
Light Sci Appl. 2025;14(1):98 - PMID: 40000616 - PMCID: PMC11862125 - DOI: 10.1038/s41377-025-01782-5
Associations between hormone therapy use and tau accumulation in brain regions vulnerable to Alzheimer's disease.
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis.
JAMA Neurol. 2025;82(4):364-75 - PMID: 40029638 - PMCID: PMC11877413 - DOI: 10.1001/jamaneurol.2025.0013
Enhanced model antigen retention in tissue through topical high-frequency ultrasound treatment.
Biomed Eng Lett. 2024;15(2):273-282 - PMID: 40026896 - PMCID: PMC11871201 - DOI: 10.1007/s13534-024-00445-5
Image-Guided Monitoring of Mitochondria and Blood-Brain Barrier Dysfunction in Amyotrophic Lateral Sclerosis Mice.
Using remote, digital, multi-day testing to characterize long-term forgetting in cognitively unimpaired older adults.
Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer's disease.
Alzheimers Res Ther. 2025;17(1):64 - PMID: 40108701 - PMCID: PMC11924723 - DOI: 10.1186/s13195-025-01711-z
Magnetic resonance imaging for suspected perianal Crohn's disease in children: a multi-reader agreement study.
Eur Radiol. 2025;35(9):5856-5863 - PMID: 40121591 - PMCID: PMC12350431 - DOI: 10.1007/s00330-025-11469-5
MineVRA: Exploring the Role of Generative AI-Driven Content Development in XR Environments through a Context-Aware Approach.
IEEE Trans Vis Comput Graph. 2025;31(5):3602-3612 - PMID: 40117142 - DOI: 10.1109/TVCG.2025.3549160
Effects of 52 weeks of precuneus rTMS in Alzheimer's disease patients: a randomized trial.
Alzheimers Res Ther. 2025;17(1):69 - PMID: 40176122 - PMCID: PMC11963669 - DOI: 10.1186/s13195-025-01709-7
Development of New Consensus Reporting Standards for Pediatric Chronic Pancreatitis.
AJR Am J Roentgenol. 2025;224(6):e2532995 - PMID: 40172169 - DOI: 10.2214/AJR.25.32995
Design Considerations for Organ-Selective Nanoparticles.
ACS Nano. 2025;19(15):14605-14626 - PMID: 40193849 - DOI: 10.1021/acsnano.5c00484
Renal Clearable H-Dots Leveraging Ligand Complexation for Enhanced Active Tumor Targeting.
703

